Status:
COMPLETED
Assessement of Viral Shedding Duration After a Respiratory Tract Infection in Oncology and Hematology Patients
Lead Sponsor:
Poitiers University Hospital
Conditions:
Respiratory Tract Viral Infection
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The purpose of this study is to assess the duration of the viral shedding in hematology and oncology patients after a respiratory tract viral infection. This duration has not been much studied in that...
Detailed Description
The development of multiplex polymerase chain reaction (PCR) tests has greatly improved the diagnosis of respiratory tract viral infections by increasing its sensitivity and the diversity of viral spe...
Eligibility Criteria
Inclusion
- Patient with solid organ cancer or haematological malignancy with or without chemotherapy
- Having symptoms of upper and/or lower respiratory tract infection
- Virus detected by PCR in nasal sample
- Signature of consent
Exclusion
- Hematological stem cell and solid organ recipients
- No health insurance
- protected people
Key Trial Info
Start Date :
February 7 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 15 2024
Estimated Enrollment :
44 Patients enrolled
Trial Details
Trial ID
NCT03389997
Start Date
February 7 2017
End Date
February 15 2024
Last Update
April 19 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Hospital of Poitiers
Poitiers, France, 86021